Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

Guilhaumou, Romain; Benaboud, Sihem; Bennis, Youssef; Dahyot‐Fizelier, Claire; Dailly, Éric; Gandia, Peggy; Goutelle, Sylvain; Lefeuvre, Sandrine; Mongardon, Nicolas; Roger, Claire; Scala‐Bertola, Julien; Lemaı̂tre, F.; Garnier, Marc

doi:10.1186/s13054-019-2378-9

Public

Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR)

Published in Critical Care • Mar 29, 2019

Authors:

Romain Guilhaumou

Sihem Benaboud

Youssef Bennis

Abstract

BACKGROUND: Beta-lactam antibiotics (βLA) are the most commonly used antibiotics in the intensive care unit (ICU). ICU patients present many pathophysiological features that cause pharmacokinetic (PK) and pharmacodynamic (PD) specificities, leading to the risk of underdosage. The French Society of P...

Subject

Medicine

Guideline

Intensive care medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!